Glycomics / Glycobiology Market

Market Leader - Glycomics / Glycobiology Market

The global glycomics market is valued at an estimated USD 1.0 billion in 2020 and is projected to reach USD 2.0 billion by 2025, at a CAGR of 13.8% during the forecast period. The growth of this market is majorly driven by the increasing R&D expenditure and funding for proteomics and glycomics research, growth of the proteomics market, and technological advancements in glycomics instrumentation. However, the high cost of tools is expected to be the major challenge for the growth of the global glycomics market during the forecast period.

The glycomics market is consolidated in nature. In 2018, Merck KGaA (Germany), Agilent Technologies (US), New England Biolabs (US), and Waters Corporation (US) were the leading players in this market. The other major players operating in this market include Other players operating in this market include Shimadzu Corporation (Japan), Takara Bio (Japan), PerkinElmer (US), Thermo Fisher Scientific (US), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Scion Instruments (UK), Hiden Analytical (UK), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), Ludger Ltd. (UK), and Cambridge Isotope Laboratories, Inc. (US).  

To know about the assumptions considered for the study download the pdf brochure

Merck KGaA was the leading player in the glycomics market, with the largest share in 2018. In the glycomics market, the company offers various products, including kits, enzymes, carbohydrates, and reagents & chemicals. Substantial business operations across all key regions, coupled with a strong brand image, make the company a leading player in this market.

Agilent Technologies was the second-largest player in the glycomics market in 2018. The company offers various enzymes, kits, and carbohydrates in the market. Through the acquisition of ProZyme, Inc. (US) in 2018, the company significantly strengthened its position in the global glycomics market.

New England Biolabs was the third-largest player in the glycomics market in 2018. The company offers a wide range of enzymes and kits in this market. Its strong distribution channels across the US have helped the company maintain its leading position in the market. To strengthen its market position, the company focuses on organic strategies such as expansions.

Related Reports:

Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (Mass Spectrometry, Chromatography), Carbohydrates, Reagents & Chemicals), Application (Disease Diagnostics), End-User (Academic) -Global Forecasts to 2025

Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
BT 2776
RI Published ON
3/6/2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Glycomics / Glycobiology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved